Segui
Daniel Gaudet
Daniel Gaudet
ecogene21 Biocluster and dept of Medicine Université de Montréal
Email verificata su umontreal.ca
Titolo
Citata da
Citata da
Anno
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
D Altshuler, JN Hirschhorn, M Klannemark, CM Lindgren, MC Vohl, ...
Nature genetics 26 (1), 76-80, 2000
23562000
Simvastatin with or without ezetimibe in familial hypercholesterolemia
JJP Kastelein, F Akdim, ESG Stroes, AH Zwinderman, ML Bots, ...
New England Journal of Medicine 358 (14), 1431-1443, 2008
16912008
Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?
I Lemieux, A Pascot, C Couillard, B Lamarche, A Tchernof, N Alméras, ...
Circulation 102 (2), 179-184, 2000
14292000
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
13162018
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised …
FJ Raal, RD Santos, DJ Blom, AD Marais, MJ Charng, WC Cromwell, ...
The Lancet 375 (9719), 998-1006, 2010
10292010
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease
JD Rioux, MJ Daly, MS Silverberg, K Lindblad, H Steinhart, Z Cohen, ...
Nature genetics 29 (2), 223-228, 2001
9732001
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
FJ Raal, EA Stein, R Dufour, T Turner, F Civeira, L Burgess, G Langslet, ...
The Lancet 385 (9965), 331-340, 2015
8612015
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
M Cuchel, EA Meagher, H du Toit Theron, DJ Blom, AD Marais, ...
The Lancet 381 (9860), 40-46, 2013
7952013
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on …
EA Stein, D Gipe, J Bergeron, D Gaudet, R Weiss, R Dufour, R Wu, ...
The Lancet 380 (9836), 29-36, 2012
6752012
Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia
C Gagné, D Gaudet, E Bruckert
Circulation 105 (21), 2469-2475, 2002
6122002
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility
AC Villani, M Lemire, G Fortin, E Louis, MS Silverberg, C Collette, N Baba, ...
Nature genetics 41 (1), 71-76, 2009
5712009
Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia
D Gaudet, VJ Alexander, BF Baker, D Brisson, K Tremblay, W Singleton, ...
New England Journal of Medicine 373 (5), 438-447, 2015
5412015
Evinacumab for homozygous familial hypercholesterolemia
FJ Raal, RS Rosenson, LF Reeskamp, GK Hovingh, JJP Kastelein, ...
New England Journal of Medicine 383 (8), 711-720, 2020
4992020
Targeting APOC3 in the familial chylomicronemia syndrome
D Gaudet, D Brisson, K Tremblay, VJ Alexander, W Singleton, SG Hughes, ...
New England Journal of Medicine 371 (23), 2200-2206, 2014
4702014
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
D Gaudet, J Méthot, S Déry, D Brisson, C Essiembre, G Tremblay, ...
Gene therapy 20 (4), 361-369, 2013
4562013
Volanesorsen and triglyceride levels in familial chylomicronemia syndrome
JL Witztum, D Gaudet, SD Freedman, VJ Alexander, A Digenio, ...
New England Journal of Medicine 381 (6), 531-542, 2019
4152019
Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region
JC Florez, N Burtt, PIW De Bakker, P Almgren, T Tuomi, J Holmkvist, ...
Diabetes 53 (5), 1360-1368, 2004
3772004
Efficacy and safety of bempedoic acid in patients with hypercholesterolemia and statin intolerance
U Laufs, M Banach, GBJ Mancini, D Gaudet, LAT Bloedon, LR Sterling, ...
Journal of the American Heart Association 8 (7), e011662, 2019
3702019
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus …
HN Ginsberg, CJ Packard, MJ Chapman, J Borén, CA Aguilar-Salinas, ...
European heart journal 42 (47), 4791-4806, 2021
3632021
Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess …
EA Stein, R Dufour, C Gagne, D Gaudet, C East, JM Donovan, W Chin, ...
Circulation 126 (19), 2283-2292, 2012
3402012
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20